Académique Documents
Professionnel Documents
Culture Documents
Scientific Officer
Immunohematology Division
National Blood Centre
Kursus Immunohematologi
19-20 Ogos 2015
1
Importance of Blood Group System
Routine ABO Blood Grouping Testing
Resolving Discrepancies in ABO Blood Grouping
Standard Operating Procedure for ABO
Discrepancies in Blood Banks
Selection of blood groups for component and
exchange transfusion in neonates
2
.
3
4
5
ISBT System Simbol Epitope/ Carrier Chromosome
001 ABO ABO Carbohydrate 9
6
Percentage of Distribution (app)
5%
15%
20% 60%
Group O Group A
Group B Group AB
7
The differences in human blood are due to the
presence or absence of certain protein molecules
called antigens and antibodies
8
RBC
Glucose
Galactose
Precursor
Substance
(stays the N-acetylglucosamine
same)
Galactose
9
RBC
Glucose
Galactose
H antigen
N-acetylglucosamine
Galactose
Fucose
10
RBC
Glucose
Galactose
A antigen N-acetylglucosamine
Galactose
N-acetylgalactosamine
Fucose
11
RBC
Glucose
Galactose
B antigen N-acetylglucosamine
Galactose
Galactose
Fucose
12
o Highly expressed on surface of a variety of
human cells and tissues, including:
- Epithelium, sensory, neurons, platelet, vascular
endothelium, kidney, heart, bowel pancreas and
lung.
o Also found on all body secretion such as
saliva, tears, milk, urine, bile, amniotic fluids &
pathologic fluids.
o Although ABH antigen have been detectable as
early as 5-6 weeks gestation, weaker expression
is expected in newborns (25-50%).
13
Naturally occurring, directed against the
missing ABO antigen
Generally IgM class antibodies – cold reacting
antibodies that bind complement
Time of appearance:
- Generally present within first 4-6 months of
life
- Reach adult level at 5-10 years of age
- ABO Titer in healthy adults varies from 4-
2048
- Begin to decrease in later years: >65 years of
age
14
*1mL of RC lyse per minute
ABO Hemolytic disease in newborn
Causes:“O” mother & “A” or “B” baby
Group O individual has anti-A, anti-B &
anti-AB
RBC Immune form: Predominantly IgG
Knowing the IgG anti-AB, anti-A & anti-
B allow the prediction or diagnosis of
HDN
Positive DAT result may indicate HDN-
Heat elution (ABO)/Acid elution
(alloantibodies)
16
17
Clinically, ABO is the most important of the
red cell antigen system identified to date
Determination of ABO compatibility
between donor and recipient is the basis of
all the pre-transfusion testing.
A person must receive ABO matched blood
because ABO incompatibilities are the
major cause of fatal transfusion reactions
18
To catch ABO incompatibilities, grouping is
done in two steps:
Forward grouping
19
TUBE METHOD GEL TESTING MICROTITER
Agglutination is Unagglutinated PLATE (AUTO)
visually red cells pass Passive
detected by the through a matrix Agglutination
adhesion of red but agglutinated where
cells are retained agglutination is
postcentrifuge visualized by
pellet spread patterns
20
Reagent Quality Control
1. A statement of criteria for acceptable reagent
performance
2. Document of reagent use
3. Appropriate corrective action
21
Name Type Physical Type of Titre Avidity Intensity
Appearance Red Cell
Anti-A Monoclonal Clear, no A ≥1:256 3-4 sec 4+
turbidity, A2 ≥1:128 5-6 sec 3+
precipitate,
particles by A2B ≥1: 64 5-6 sec 3+
visual B -- -- Neg
inspection & O -- -- Neg
Blue colour
liquid
23
• The ratio of serum to cells markedly affects
the sensitivity of agglutination tests.
24
Sufficient (1ml, 3ml or 10ml)
Correct Tube (Anticoagulant-EDTA/ Plain
Tube w/o gel)
Non-hemolysed – may cause technologist
to miss hemolysis as a positive endpoint in
testing
Specimen not drawn from IV site – dilute
antibodies/may cause rouleaux
Specimen, form & tube tallied
Current results agree with historical
Non-hemolysed & hemolysed
sample
results
Previous history of
transfusion/pregnancies
25
Put 2 drops of antisera anti-A, anti-B, anti-AB and
anti-D in each labeled tube
2:1
Put one drop of ABO cell into the labelled tube correctly.
2:1
Tubes labeled with respective known cell & patient ID no.
27
Mix the tubes well for a few sec
(leave for RT@3-5min) then
centrifuge at 3500rpm for 15 sec.
28
Partial or Complete
hemolysed is a positive
reaction
Mixed Field Agglutination (Post Transfusion)
•ABO Testing
Can be seen in A, B and AB individuals who have received O units.
The antisera reacts with patient RBC but not transfused O cell
•Antibody Screening
Can also be seen post transfusion if a person makes an antibody to
antigen on donor cells; antibody agglutinates on donor cell, but
not their own cell.
30
Forward Grouping Reverse Grouping Interpretation
4+ 0 4+ 0 3+ 0 A
0 4+ 4+ 3+ 0 0 B
4+ 4+ 4+ 0 0 0 AB
0 0 0 3+ 3+ 0 O
0 0 0 3+ 3+ 3+ ? Bombay
Type of ABO Gelcards
32
33
CAT vs tube method
Standardization
Stability
No wash steps
Consistent &
reproducible result
Less sample volume
Cost
Time
Specific incubator &
centrifuge
34
Biorad (Diamed) Grifols
Add 10µl or 12.5µl of the red Add 10µl of the red cell into
cell into A/B/D/ctrl mirotube A/B/D/ctrl mirotube
Pippete 50µl ID-DiaCell A1, 50µl Pippete 50µl Serigrup Diana A1,
ID-DiaCell B 50µl Serigrup Diana B
REVERSE
36
Drying, discoloration, bubbles, crystals, other artifacts,
opened or damaged seals may indicate product
alteration
Diamed: ID Incubator 15min, ID Centrifuge 10min
Grifols: DG THERM incubator 15min, DG SPIN
centrifuge 9 min
37
If the control microtube is positive the results cannot be use!!
38
Microplate techniques can be used to test for
antigens on red cells and for antibodies in serum.
39
Olympus PK7300 – Donor Blood Grouping Confirmation
40
41
Correlate ABO testing with the expected
result and define various ways to resolve an
ABO discrepancies
Identify various clerical and technical errors
that can affect ABO Interpretation
Discuss the effect of disease on the
expression of ABH antigen.
Forward Grouping Reverse Grouping
0 0 O? 0 + A?
0 0 O? + 0 B?
+ + AB? 0 + A?
+ + AB? + + O?
Yes
Proceed to pre- Is discrepancy resolved?
transfusion testing
No
45
Initial steps to resolve discrepancy include:
Clerical check of specimen and paperwork
Determine patient’s age
Diagnosis
History of transfusion, transplants or
pregnancies
Current medications
46
Weak/ Missing Red Extra Red Cell Mixed field red cell
Cell reactivity Activity activity
Autoagglutinins/ Fetomaternal
ABO subgroup
excess protein hemorrhage
Excessive soluble
Acquire B Transplanted
blood group
substance
antigen bone marrow
Transplantation Transplantation
Exchange
transfusion
Twin or
Leukemia/ B(A)
dispermic
Malignancy phenomenon
chimerism
47
Weak/Missing Extra serum
serum reactivity activity
Hypogamma
Excess serum protein
globulinemia
Transfusion of
Transplantation
plasma component
Infusion of
intravenous IG
48
Transfusion delayed until
discrepancy resolved
49
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti-A,B A1 Cells B Cells
0 3+ 4+ 0 0
Group I discrepancies
These discrepancies are between forward and
reverse grouping due to weak reaction or missing
antibodies.
51
Some of the common populations with
discrepancies in this group:
a) Newborns and Elderly patients
b) Patient with leukemias (CLL)
Hypogamma-
c) Patients with lymphomas globulinemia
d) Patient using immunosuppressive drugs
e) Patient with Bone Marrow transplant
f) Patients with congenital
agammaglobunolinemia
g) Patient with immunodeficiency disease
52
Eliminate all technical errors
Enhance the reverse group reaction by
incubating serum with A and B cells at RT for 15
to 30 min
If no reaction, incubate serum-cell mixture at
40C for 15 to 30 min
An auto-control and an O cell control must
always tested concurrently – cold agglutinins
Rare Case: Chimerism-presence of 2 cell
populations in a single individual. Occurs in twins
or dispermy
53
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti- A1 B Cells O cell Auto
A,B Cells C
Patient Z 0 3+ 4+ 0 0 0 0
30’ RT 0 3+ 4+ 0 0 0 0
30’ 4C 0 3+ 4+ 1+ 0 0 0
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti-A,B A1 Cells B Cells
0 1+ 1+ 4+ 0
Group II discrepancies
These discrepancies are between forward and
reverse grouping due to weak reaction or missing
antigens.
This group is the least frequently encountered.
55
Some of the common populations with discrepancies
in this group:
a) Subgroups of A and/or subgroups of B
b) Leukemia
c) Hodgkin’s disease
d) Stomach or Pancreas CA – Excess amounts of Blood
group-specific soluble substances present in plasma
e) “Acquired B” Phenomenon –limited to group A1
individual with : Lower GI tract disease, Intestinal
Obstruction or malignancy of stomach &
Intestine, Gram negative septicemia (E. coli)
f) Antibodies to low incidence antigens in reagent A or
anti-B
56
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti-A,B A1 Cells B Cells
4+ 2+ 4+ 0 4+
57
Incubate test mixture at RT for 30 minutes, if
negative result, reduce temp to 40C
Washing patient’s cell with saline - remove
excess amount of BGSS that neutralize reagent.
58
Acquired anti-B antigen not agglutinate with
Anti-B at pH > 8.5 or pH <6.0 (using acidified
human anti-B/ autologous RBC / modified BS-1
lectin)
61
b) Elevated levels of fibrinogen
c) Plasma expanders such as dextran and polyvinyl
pyrrolidone
c)Wharton’s jelly – gelatinous substance derive
from connective tissue that is found from cord
blood
Some are caused by Rouleaux formation-
Rouleaux or red cells result from a stacking of
erythrocytes that adhere in a coin-link fashion
giving the appearance of agglutination.
62
Washing the patient’s red cells with saline or
saline replacement technique in case of rouleaux
formation (multiple myeloma, reverse albumin-
to-globulin ratio or given plasma expanders) &
repeat the test.
64
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti-A,B A1 Cells B Cells O cells AC
4+ 4+ 4+ 2+ 2+ 2+ 2+
66
Forward Grouping Reverse Grouping
Anti-A Anti-B Anti-A,B A1 Cells B Cells
4+ 4+ 4+ 1+ 1+
67
68
Occasionally weak subgroups of A may
present practical problems.
If Ax donor is mistyped as group O, this is
potentially dangerous
The group O patient posses anti-A,B which
agglutinates and lyses Ax red cells.
Occasional problems also arise when A2 or
A2B individuals demonstrate Anti-A1 in their
serum.
69
Degree of red cell agglutination by anti-A and
anti-A1
Degree of red cell agglutination by human
and some monoclonal antisera
Degree of H antigen (anti-H lectin and Ulex
europaeus) expression
Presence or absence of anti-A1
Presence of A and H in saliva
Further Investigation:
Adsorption and elution studies
Family (pedigree) studies
Red Cell Red Cell Reactions with Antisera Serum reactions with reagent red
Phenoty or Lectins cells
ping Anti-A Anti-B Anti- Anti-H A1 cell B cell O cell Saliva
A,B (Secret
or)
A1 4+ 0 4+ 0 0 4+ 0 A&H
A2 4+ 0 4+ 2+ 0/2+ 4+ 0 A&H
A3 2+ mf 0 2+ mf 3+ 0/2+ 4+ 0 A&H
Ax 0/± 0 1-2+ 4+ 0/2+ 4+ 0 H
B 0 4+ 4+ 0 4+ 0 0 B&H
B3 0 1+ mf 2+ mf 4+ 4+ 0 0 B&H
Bx 0 0/± 0/2+ 4+ 4+ 0 0 H
B(A) ±/2+ 4+ 4+ 0 4+ 0 0 B&H
71
Present as an alloantibody in serum of 1%-8% A2
individuals and 22% to 35% of A2B individual
Group O serum contains a mixture of Anti-A and
Anti-A1
Anti-A1 is considered clinically significant if
reactive at 37ºC.
To resolve an ABO discrepancy caused by anti-
A1, red cells should be tested with Dolichos
biflorus lectin, which agglutinates A1 but not A2
Group A2 patients with an anti-A1 that is reactive
at 37ºC should be transfused with group O or A2
red cells only.
Group A2B : O,A2, A2B or B red cells
72
Classical Bombay (Oh) Para-Bombay Phenotype
Para-Bombay B 0 ± ± 0 4+ 1+ 4+ B&H
*Literature on Para-bombay often have different description from one individual to another.
Further readings:
Reid ME, Lomas-Francis C: The Blood Group Antigen Factbook, 2nd ed. London, Academic Press,
Elsevier, 2004
Spitalnik PF, Spitalnik SL: Human carbohydrate blood group systems, 3rd ed. Philadelphia,
Lippincott Williams and Wilkins, 2002
74
Autoanti-H and Autoanti-HI
- May Cause ABO discrepancies
- Clinically in-significant. Can occur in Group A1, A1B
- Transfuse group specific or group O RBC should have a
normal in-vivo survival
75
76
77
Must
Report !
78
79
Paed Pack group O Paed FFP group AB
80
Blood Group of Mother
O A B AB
O O O O O
Blood A EO A EO A
Group
Neonate B EO EO B B
AB EO A B AB
**Emergency O (EO) blood is group O RhD positive whole blood with low
titers of Anti-A and Anti-B, negative for hemolysin test
O O, AB, A, B O
A A, AB A
B B, AB B
AB AB (A or B if AB A or B
unobtainable)
82
AABB Technical Manual , 18th Edition
Modern Blood Banking & Transfusion Practice, 4th Edition
Textbook of Blood Banking and Transfusion Medicine, 2nd Edition
CLS 422 Clinical Immunohematology I
American Red Cross: ABO discrepancies
Transfusion Practice Guidelines for Clinical and Laboratory
Personnel, National Blood Center (Un-publish, 2014)
SOP Transfusion Medicine Unit 2015
SOP Red Cell Serology Unit 2015
83
All Immunohematology Staff and
Organizing Committee of
Immunohematology Course/Workshop 2015
84